MedPath
FDA Approval

NEO-POLY-BAC

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 4, 2010
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bacitracin(400 [USP'U] in 1 g)
Polymyxin B(10000 [USP'U] in 1 g)
Neomycin(3.5 mg in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Bausch & Lomb Incorporated

196603781

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bausch & Lomb Incorporated

Butler Animal Health Supply

Bausch & Lomb Incorporated

807927397

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NEO-POLY-BAC

Product Details

NDC Product Code
11695-1405
Application Number
ANDA064064
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
September 30, 2010
Code: 89Y4M234ESClass: ACTIBQuantity: 400 [USP'U] in 1 g
Code: 19371312D4Class: ACTIBQuantity: 10000 [USP'U] in 1 g
NeomycinActive
Code: 057Y626693Class: ACTIBQuantity: 3.5 mg in 1 g
PETROLATUMInactive
Code: 4T6H12BN9UClass: IACT
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath